应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
BK4007 制药
休市中 05-01 16:00:00 EDT
830.95
+5.08
+0.61%
最高
839.28
最低
825.93
成交量
4.49亿
今开
825.93
昨收
825.87
日振幅
1.62%
总市值
0.00
流通市值
0.00
总股本
0.00
成交额
151.93亿
换手率
--
流通股本
0.00
市净率
5.146456
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
诚益生物冲刺港股：年亏损4460万美元 业务深度绑定阿斯利康
雷递网 · 05-03 10:35
诚益生物冲刺港股：年亏损4460万美元 业务深度绑定阿斯利康
Arvinas宣布Veppanu（Vepdegestrant）获FDA批准用于治疗ESR1突变、ER+/HER2-晚期乳腺癌
美股速递 · 05-02 00:46
Arvinas宣布Veppanu（Vepdegestrant）获FDA批准用于治疗ESR1突变、ER+/HER2-晚期乳腺癌
FDA批准Vepdegestrant用于ER阳性、HER2阴性、ESR1突变晚期或转移性乳腺癌
美股速递 · 05-02 00:28
FDA批准Vepdegestrant用于ER阳性、HER2阴性、ESR1突变晚期或转移性乳腺癌
Esperion Therapeutics：若合并未完成 Essence母公司需支付6830万美元终止费——SEC文件披露
美股速递 · 05-02 00:08
Esperion Therapeutics：若合并未完成 Essence母公司需支付6830万美元终止费——SEC文件披露
纳斯达克 100 指数期货转为上涨，抹去早前跌幅
链捕手 · 05-01 20:20
纳斯达克 100 指数期货转为上涨，抹去早前跌幅
Esperion Therapeutics股东将获每股3.16美元分红及最高1亿美元里程碑款项
美股速递 · 05-01 19:00
Esperion Therapeutics股东将获每股3.16美元分红及最高1亿美元里程碑款项
Eton Pharmaceuticals携Eton Cares计划及独家专业药房分销渠道重新推出Hemangeol®（普萘洛尔）口服溶液
美股速递 · 05-01 18:51
Eton Pharmaceuticals携Eton Cares计划及独家专业药房分销渠道重新推出Hemangeol®（普萘洛尔）口服溶液
Leerink Partners将礼来公司股票目标价格上调至1,119美元
中金财经 · 05-01 18:27
Leerink Partners将礼来公司股票目标价格上调至1,119美元
阿斯利康乳腺癌候选药物未获FDA咨询委员会投票通过
环球市场播报 · 05-01 16:14
阿斯利康乳腺癌候选药物未获FDA咨询委员会投票通过
美国证券交易委员会批准纳斯达克与基准指数挂钩的预测市场期权提案
环球市场播报 · 05-01 10:04
美国证券交易委员会批准纳斯达克与基准指数挂钩的预测市场期权提案
Sonoma制药公司与Dawson James证券公司达成承销协议
美股速递 · 05-01 05:19
Sonoma制药公司与Dawson James证券公司达成承销协议
Sonoma制药公司拟以每股1.35美元公开发行296.3万单位——SEC文件披露
美股速递 · 05-01 05:19
Sonoma制药公司拟以每股1.35美元公开发行296.3万单位——SEC文件披露
重点个股回顾：Blue Owl、谷歌A、高通、Meta Platforms股价异动
投资观察 · 05-01 05:02
重点个股回顾：Blue Owl、谷歌A、高通、Meta Platforms股价异动
Phibro Animal Health Corporation将循环信贷额度提升1.25亿美元至4.35亿美元
美股速递 · 05-01 04:42
Phibro Animal Health Corporation将循环信贷额度提升1.25亿美元至4.35亿美元
强生承诺继续为已终止的CD20单靶点及CD19-CD20双靶点CAR-T研究项目患者提供支持
美股速递 · 05-01 04:33
强生承诺继续为已终止的CD20单靶点及CD19-CD20双靶点CAR-T研究项目患者提供支持
Contineum Therapeutics公司Pipe-791药物1B期临床试验达到安全性与耐受性主要终点
美股速递 · 05-01 04:07
Contineum Therapeutics公司Pipe-791药物1B期临床试验达到安全性与耐受性主要终点
Trevi Therapeutics宣布在美国胸科学会2026年国际会议上进行口头报告及多篇海报展示
美股速递 · 05-01 04:06
Trevi Therapeutics宣布在美国胸科学会2026年国际会议上进行口头报告及多篇海报展示
Contineum Therapeutics公布慢性疼痛探索性Pipe-791 1B期试验积极顶线数据
美股速递 · 05-01 04:06
Contineum Therapeutics公布慢性疼痛探索性Pipe-791 1B期试验积极顶线数据
Axsome Therapeutics宣布FDA批准Auvelity®用于治疗阿尔茨海默病相关痴呆激越症状
美股速递 · 05-01 02:08
Axsome Therapeutics宣布FDA批准Auvelity®用于治疗阿尔茨海默病相关痴呆激越症状
美国FDA提议将诺和诺德、礼来减肥药移出批量配药清单，两家药企迎来利好
环球市场播报 · 04-30
美国FDA提议将诺和诺德、礼来减肥药移出批量配药清单，两家药企迎来利好
加载更多
公司概况
公司名称：
制药
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"BK4007","market":"US","secType":"PLATE","nameCN":"制药","latestPrice":830.9504,"timestamp":1777665599999,"preClose":825.87427,"halted":0,"volume":448845112,"delay":0,"changeRate":0.006146,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":5.076111,"latestTime":"05-01 16:00:00 EDT","open":825.92804,"high":839.28235,"low":825.92804,"amount":15192916691.21488,"amplitude":0.01617,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777881600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.146456,"peRate":27.414474,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK4007","defaultTab":"news","newsList":[{"id":"2632260556","title":"诚益生物冲刺港股：年亏损4460万美元 业务深度绑定阿斯利康","url":"https://stock-news.laohu8.com/highlight/detail?id=2632260556","media":"雷递网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632260556?lang=zh_cn&edition=full","pubTime":"2026-05-03 10:35","pubTimestamp":1777775725,"startTime":"0","endTime":"0","summary":"诚益生物开曼有限公司（简称：“诚益生物”）日前更新招股书，准备在港交所上市。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260503/6391340131178578595887971.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260503/6391340131178578595887971.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n33522/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["LU2236285917.USD","LU2237443465.HKD","LU2462157665.USD","BK4588","LU2237443549.SGD","VXUS","LU1829250122.USD","LU2237443895.HKD","LU2237443382.USD","LU2237443622.USD","LU0889565916.HKD","AZN","LU2417539215.USD","LU2456880835.USD","LU0320765992.SGD","BK4585","BK4007","LU0289739699.SGD","BK4568","LU0058720904.USD","LU2237443978.SGD","IE00B3T34201.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131483490","title":"Arvinas宣布Veppanu（Vepdegestrant）获FDA批准用于治疗ESR1突变、ER+/HER2-晚期乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1131483490","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131483490?lang=zh_cn&edition=full","pubTime":"2026-05-02 00:46","pubTimestamp":1777653983,"startTime":"0","endTime":"0","summary":"生物制药公司Arvinas Holding Company LLC（简称Arvinas）迎来重大里程碑——其创新药物Veppanu（通用名：Vepdegestrant）正式获得美国食品药品监督管理局（FDA）的上市批准。该药物将用于治疗携带ESR1突变、雌激素受体阳性且人表皮生长因子受体2阴性的晚期乳腺癌患者。\n此次获批为特定乳腺癌亚型患者提供了新的治疗选择，标志着Arvinas在蛋白降解疗法领域取得了实质性突破。Veppanu作为一种新型的口服PROTAC蛋白降解剂，其作用机制旨在选择性地靶向并降解雌激素受体，为面临治疗挑战的晚期乳腺癌患者带来新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ARVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141910392","title":"FDA批准Vepdegestrant用于ER阳性、HER2阴性、ESR1突变晚期或转移性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1141910392","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141910392?lang=zh_cn&edition=full","pubTime":"2026-05-02 00:28","pubTimestamp":1777652939,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式批准Vepdegestrant药物，该药物专门用于治疗雌激素受体（ER）阳性、人表皮生长因子受体2（HER2）阴性且携带ESR1基因突变的晚期或转移性乳腺癌患者。此项批准为这类特定亚型的乳腺癌患者提供了新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE00BLSP4239.USD","LU0122379950.USD","BK4581","IE00B19Z3B42.SGD","SG9999002232.USD","BK4007","BK4550","LU0306807586.USD","SG9999011175.SGD","LU0985481810.HKD","IE00BBT3K403.USD","LU1894683348.USD","IE00B3T34201.USD","IE00B19Z3581.USD","BK4599","IE000M9KFDE8.USD","SGXZ57979304.SGD","LU0289739699.SGD","BK4533","LU0058720904.USD","BK4588","LU1894683264.USD","LU0225284248.USD","LU1066051498.USD","LU0321505439.SGD","LU0868494617.USD","SG9999001176.SGD","SG9999002224.SGD","SG9999013999.USD","BK4592","LU1066053197.SGD","LU1057294990.SGD","LU0321505868.SGD","LU0456855351.SGD","IE00BLSP4452.SGD","IE0002270589.USD","ELEV","BK4568","LU0225771236.USD","SG9999001176.USD","LU0306806265.USD","LU0234572021.USD","LU1883839398.USD","LU1023059063.AUD","LU0170899867.USD","BK4585","SG9999003800.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145063887","title":"Esperion Therapeutics：若合并未完成 Essence母公司需支付6830万美元终止费——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1145063887","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145063887?lang=zh_cn&edition=full","pubTime":"2026-05-02 00:08","pubTimestamp":1777651716,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会（SEC）的文件披露，Esperion Therapeutics Inc. 与Essence母公司之间的合并协议包含一项关键条款：若此项合并交易最终未能完成，Essence的母公司需向Esperion公司支付高达6830万美元的终止费用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESPR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632612555","title":"纳斯达克 100 指数期货转为上涨，抹去早前跌幅","url":"https://stock-news.laohu8.com/highlight/detail?id=2632612555","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632612555?lang=zh_cn&edition=full","pubTime":"2026-05-01 20:20","pubTimestamp":1777638039,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据 Gate 行情数据显示，纳斯达克 100 指数期货抹去早前跌幅，现已转为上涨。 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2262071","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDX","HXC","QQQJ","QDTE","JEPQ","QLD","TQQY","NVIW.SI","FTEC","MNQmain","QYLG",".IXIC","SQQQ","QQQM","QQQE","QID","IYW","QQQY","GPIQ","ONEQ","QQQA","BK4007","QQQ","PSQ","TQQQ","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106315354","title":"Esperion Therapeutics股东将获每股3.16美元分红及最高1亿美元里程碑款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1106315354","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106315354?lang=zh_cn&edition=full","pubTime":"2026-05-01 19:00","pubTimestamp":1777633229,"startTime":"0","endTime":"0","summary":"Esperion Therapeutics Inc. 宣布其股东将获得一笔可观的现金回报。根据公司披露的方案，每位股东将按持股比例获得每股3.16美元的特别分红。\n此外，该协议还包含一项具有激励性质的潜在收益。股东未来可能有权分享最高达1亿美元的里程碑付款，具体金额将取决于公司后续达成的特定业绩目标或战略节点。\n这一综合回报方案显著提升了股东价值，反映出公司当前稳健的财务状况以及对未来发展的信心。资金分配计划旨在即时回报投资者信任，同时通过里程碑条款与公司长期成长潜力深度绑定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ESPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131923378","title":"Eton Pharmaceuticals携Eton Cares计划及独家专业药房分销渠道重新推出Hemangeol®（普萘洛尔）口服溶液","url":"https://stock-news.laohu8.com/highlight/detail?id=1131923378","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131923378?lang=zh_cn&edition=full","pubTime":"2026-05-01 18:51","pubTimestamp":1777632680,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals, Inc. (ETON) 宣布，其旗下产品Hemangeol®（普萘洛尔）口服溶液已正式重新上市。此次重启伴随着公司推出的\"Eton Cares\"患者支持计划，旨在为用药患者提供全方位的协助。同时，该产品将通过独家专业药房渠道进行分销，以确保药品的可及性与专业服务支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632616546","title":"Leerink Partners将礼来公司股票目标价格上调至1,119美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2632616546","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632616546?lang=zh_cn&edition=full","pubTime":"2026-05-01 18:27","pubTimestamp":1777631221,"startTime":"0","endTime":"0","summary":"Leerink Partners将礼来公司股票目标价格从1,058美元上调至1,119美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260501/32196259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU2237443382.USD","LU0320765059.SGD","LU1127390331.HKD","LLY","LU2324357040.USD","LU2491049909.HKD","LU0708995401.HKD","LU2462157665.USD","LU2361045086.USD","LU0109394709.USD","LU1917777945.USD","LU1868837300.USD","LU2361044949.HKD","LU0823434583.USD","LU0256863811.USD","LU0203201768.USD","LU2746668461.USD","LU2063271972.USD","LU0238689110.USD","LU1145028129.USD","LU0672654240.SGD","LU1267930730.SGD","LU0316494557.USD","IE00BJT1NW94.SGD","LU0079474960.USD","LU0114720955.EUR","GB00BDT5M118.USD","LU2112291526.USD","LU2168564065.EUR","LU0820562030.AUD","LLYX","BK4599","LU0096364046.USD","BK4007","LU2552382215.SGD","LU2746668974.SGD","LU0106261372.USD","LU0823434740.USD","IE0001KFT4U8.USD","LU1868837136.USD","LU0882574055.USD","LU2471134952.CNY","LU0006306889.USD","LU0432979614.USD","LU2237443895.HKD","LU0353189680.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU0689472784.USD","LU0234572021.USD","LU1974910355.USD","LU0964807845.USD","IE00B1BXHZ80.USD","LU2265009873.SGD","SG9999014880.SGD","SG9999015986.USD","SG9999015952.SGD","LU0471298694.HKD","LU2237438978.USD","LU2264538146.SGD","SG9999014898.SGD","LU1983299246.USD","LU2602419157.SGD","LU0210536198.USD","SG9999013999.USD","IE00B4R5TH58.HKD","LU0385154629.USD","SG9999014914.USD","LU1323610961.USD","LU0471298777.SGD","LU1035775433.USD","LU1064131342.USD","LU1814569148.SGD","IE00BJJMRZ35.SGD","LU0820561818.USD","LU2111349929.HKD","BK4585","IE00BFSS7M15.SGD","IE00BJJMRX11.SGD","LU2089984988.USD","LU2168564149.EUR","LU1623119135.USD","LU2357305700.SGD","LU1551013342.USD","LU0058720904.USD","LU2023250330.USD","LU0456855351.SGD","LU0466842654.USD","LU2471134879.HKD","LLYZ","LLII","LU2471134523.USD","LU0889565916.HKD","LU0820561909.HKD","LU0266013472.USD","LU1057294990.SGD","LU2756315664.SGD","LU2237443978.SGD","BK4533","LU2552382132.HKD","IE00BKPKM429.USD","LU1069344957.HKD","LU1712237335.SGD","LU1720051017.SGD","LU0353189763.USD","LU2023251221.USD","LU0256863902.USD","ELIS","LU1366192091.USD","LU0122379950.USD","LU1988902786.USD","LU0203202063.USD","LU1232071149.USD","LU2106854487.HKD","SGXZ51526630.SGD","BK4516","IE0009355771.USD","LU2023250504.SGD","LU0683600562.USD","LU2168564222.USD","LU1548497426.USD","IE00B7KXQ091.USD","SGXZ99366536.SGD","LU2089284900.SGD","IE00BJJMRY28.SGD","LU2417539215.USD","LU2237443465.HKD","LU2750360641.GBP","LU0158827948.USD","LU0198837287.USD","LU0823416689.USD","LU1551013425.SGD","LU2108987350.USD","IE0005OL40V9.USD","SGXZ31699556.SGD","IE00B4JS1V06.HKD","LU0786609619.USD","LU2213496289.HKD","LU0417517546.SGD","IE00BWXC8680.SGD","SG9999015978.USD","SG9999001176.SGD","ELIL","LU1280957306.USD","LU2896262040.SGD","SG9999018865.SGD","IE00BJLML261.HKD","LU1093756168.USD","SG9999018857.SGD","LU2471134796.USD","SG9999015945.SGD","LU2461242641.AUD","LU0094547139.USD","LU0943347566.SGD","LU0323591593.USD","LU1093756325.SGD","IE00BK4W5L77.USD","LU1868836591.USD","LU2237443622.USD","LU1291159041.SGD","LU1023059063.AUD","BK4534","LU2468319806.SGD","LU0158827781.USD","LU2750360997.AUD","IE00BKDWB100.SGD","SGXZ81514606.USD","LU2756315318.SGD","LU2491050154.USD","LU2237443549.SGD","LU2211815571.USD","LU2491050071.SGD","IE0004445015.USD","LU2087625088.SGD","SG9999014906.USD","LU1989771016.USD","LU0354030438.USD","LU2236285917.USD","LU1868836757.USD","LU0289739699.SGD","LU0787776722.HKD","LU0882574139.USD","LU1868836914.USD","IE00B2B36J28.USD","LU0133085943.USD","LU0109391861.USD","IE00BFSS8Q28.SGD","LU2168563687.JPY","LU2552382058.USD","SG9999017495.SGD","SGXZ57979304.SGD","BK4581","LU2361044865.SGD","IE0004445239.USD","LU2456880835.USD","SG9999001176.USD","LU0061475181.USD","LU1629891620.HKD","LU1061106388.HKD","IE00B1XK9C88.USD","LU0640476718.USD","LU0097036916.USD","LU0354030511.USD","IE0002141913.USD","IE00BK4W5M84.HKD","LU2168564495.EUR","LU2089283258.USD","LU1804176565.USD","LU1720051108.HKD","IE00B775H168.HKD","LU0225283273.USD","BK4588","LU2271345857.HKD","IE00BN29S564.USD","LU2028103732.USD","LU2360106947.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632504618","title":"阿斯利康乳腺癌候选药物未获FDA咨询委员会投票通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2632504618","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632504618?lang=zh_cn&edition=full","pubTime":"2026-05-01 16:14","pubTimestamp":1777623240,"startTime":"0","endTime":"0","summary":"在乳腺癌候选药物未能在一项关键的咨询委员会投票中获得支持后，英国制药集团阿斯利康表示，该公司将继续与美国监管机构合作，对该药物进行审查。该公司周四晚间表示，美国食品药品管理局的肿瘤药物咨询委员会以6比3的投票结果，对乳腺癌治疗候选药物camizestrant的获益-风险评估给出否定性意见。阿斯利康的股价在周五开盘交易中下跌了约1.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-01/doc-inhwktza5459710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2237443465.HKD","BK4007","LU0889565916.HKD","LU1829250122.USD","LU0109394709.USD","BK4585","LU2237443895.HKD","LU0058720904.USD","LABU","LU0320765992.SGD","LU0289739699.SGD","LU2237443622.USD","BK4568","LU2462157665.USD","IE00B3T34201.USD","LU2237443382.USD","LU2417539215.USD","AZN","LU2456880835.USD","LU2237443978.SGD","LU2237443549.SGD","BK4588","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632696740","title":"美国证券交易委员会批准纳斯达克与基准指数挂钩的预测市场期权提案","url":"https://stock-news.laohu8.com/highlight/detail?id=2632696740","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632696740?lang=zh_cn&edition=full","pubTime":"2026-05-01 10:04","pubTimestamp":1777601040,"startTime":"0","endTime":"0","summary":"根据一份监管命令，美国证券交易委员会周四批准了纳斯达克期权交易平台的一项提案，允许其上市并交易一种与主要指数挂钩的新类别的股市预测工具。 由纳斯达克运营的美国电子期权交易所纳斯达克MRX将首先推出与纳斯达克100指数及纳斯达克100微型指数挂钩的期权产品。微型指数的基准值相当于纳斯达克100指数总市值的1/100。 该委员会批准了纳斯达克于3月通过提交的加速审批申请，称该提案“符合法案要求”，且未引发新的监管担忧。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-01/doc-inhwkccp0751423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NDAQ","QLD","QQQE","QQQJ","TQQY","MNQmain","TQQQ","ONEQ",".IXIC","NDX","QDTE","NVIW.SI","QQQA","BK1147","HXC","SQQQ","QYLG","BK4007","IYW","PSQ","JEPQ","QQQM","FTEC","GPIQ","QQQ","QQQY","QID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191505631","title":"Sonoma制药公司与Dawson James证券公司达成承销协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1191505631","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191505631?lang=zh_cn&edition=full","pubTime":"2026-05-01 05:19","pubTimestamp":1777583952,"startTime":"0","endTime":"0","summary":"2026年4月24日，Sonoma Pharmaceuticals, Inc.与Dawson James证券公司正式签署承销协议。该协议已通过美国证券交易委员会（SEC）备案程序，标志着双方资本合作进入实质性阶段。\n根据公开披露的SEC文件显示，此次承销协议的签署将为企业后续资本运作奠定基础。作为专业医疗健康领域的上市公司，Sonoma Pharmaceuticals此举引发市场对其未来战略布局的广泛关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4007","SNOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125326268","title":"Sonoma制药公司拟以每股1.35美元公开发行296.3万单位——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1125326268","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125326268?lang=zh_cn&edition=full","pubTime":"2026-05-01 05:19","pubTimestamp":1777583952,"startTime":"0","endTime":"0","summary":"根据最新提交的美国证券交易委员会文件显示，Sonoma Pharmaceuticals, Inc. 宣布将启动新一轮公开发行计划。该公司拟以每单位1.35美元的价格，发行总计2,962,962个交易单位。此次融资方案细节已通过正式监管文件对外公布，标志着这家专业制药企业资本运作的重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4007","SNOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145974352","title":"重点个股回顾：Blue Owl、谷歌A、高通、Meta Platforms股价异动","url":"https://stock-news.laohu8.com/highlight/detail?id=1145974352","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145974352?lang=zh_cn&edition=full","pubTime":"2026-05-01 05:02","pubTimestamp":1777582949,"startTime":"0","endTime":"0","summary":"Blue Owl Capital Inc.最新季报表现超越华尔街预期，整体募资势头强劲，成功抵消了其旗舰私募信贷部门增长停滞的影响。股价应声上涨9.8%。谷歌母公司Alphabet 首季营收激增22%，净利润跃升81%，这主要得益于人工智能竞赛推动其云业务快速增长。股价大幅攀升近10%。苹果 公布的数据显示，受iPhone 17系列机型激发消费者热情推动，iPhone季度营收增长21.7%，用户换机需求保持旺盛。包括季度销售额和毛利率在内的整体业绩均超出华尔街预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0c964770f5704d909e4b6d2c40dad5fa","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU0348723411.USD","HK0000914660.USD","LU0314106906.USD","LU0894486033.HKD","LU0690374615.EUR","SGXZ51526630.SGD","LU0029864427.USD","LU1221951129.SGD","LU2125909247.SGD","SG9999014542.SGD","LU2100268510.USD","BK4514","LU0456855351.SGD","AAPU","LU2506951875.HKD","LU0949170772.SGD","LU1244550577.SGD","LU1066053197.SGD","BK4527","LU0557290698.USD","LU2361044865.SGD","BK4097","LU0882574055.USD","IE0002270589.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0545039389.USD","LU0985489474.SGD","LU2417539215.USD","LU2210150020.SGD","LLYZ","IE00B3SWFQ91.USD","LU0316494557.USD","LU0545562505.USD","LU1951200564.SGD","BK4141","IE00BKDWB100.SGD","LU0689472784.USD","LU0950375773.USD","LU0960925559.SGD","IE000SO60NU8.SGD","LU2047632596.USD","BK4543","LU2028103732.USD","LU2237957902.USD","LU1069344957.HKD","LU0128525929.USD","LU1880398554.USD","SGXZ31699556.SGD","IE00BQXX3C00.GBP","LU1720051017.SGD","LU1989764748.USD","LU2286300806.USD","LU2023250843.SGD","LU2602419157.SGD","LU0171293334.USD","MSFY","LU1917777945.USD","LU0149725797.USD","IE00BBT3K403.USD","LU0095938881.EUR","HK0000306701.USD","LU2543165471.USD","LU2954938101.SGD","LU0648000940.SGD","LU1582986433.USD","LU0795875086.SGD","LU0889565833.HKD","LU1815336760.USD","LU0310800965.SGD","LU2552382058.USD","ELIS","LU0788109477.HKD","LU0889566641.SGD","BK4532","LU0203202063.USD","BK4612","LU0784384876.USD","IE00B1XK9C88.USD","LU0289961442.SGD","LU1066051811.HKD","LU1301847155.USD","LU0080751232.USD","LU0106261372.USD","AAPY","LU2097344357.USD","LU1551013425.SGD","IE00B3S45H60.SGD","LU0203345920.USD","LU0942090050.USD","LU1815333072.USD","LU0174119429.USD","BK4535","LU0289960550.SGD","IE000WAW04H5.SGD","LU0096364046.USD","LU0784385840.USD","LU0345774631.USD","LU1188199696.SGD","LU2362540622.SGD","SG9999015358.SGD","LU1037948541.HKD","LU0187121727.USD","IE00BJT1NW94.SGD","LU0210533765.USD","LU2272731600.USD","LU0143551892.USD","LU1236620834.HKD","LU1791710582.SGD","LU0170899867.USD","LU2360032135.SGD","LU2403377893.USD","IE000KEQY171.SGD","LU1244550494.USD","LLYX","LU2756315318.SGD","BK4574","LU1064131342.USD","LU2237443978.SGD","LU1032466523.USD","LU2360106780.USD","LU2265009873.SGD","LU0661504455.SGD","SG9999002232.USD","LU1206712785.SGD","LU2452424414.USD","LU2087621335.USD","SGXZ23171101.USD","LU0964807845.USD","LU0251142724.SGD","SG9999015341.SGD","LU0128525689.USD","LU1003077747.HKD","BK4592","LU0058720904.USD","LU1235294995.USD","LU1582987324.SGD","LU0354030438.USD","LU2468319806.SGD","LU2106854487.HKD","LU1670756490.USD","LU0107464264.USD","LU1202635105.USD","IE00B19Z3581.USD","LU0308772762.SGD","LU2860962120.EUR","LU2092937221.SGD","LU0354030511.USD","LU0320765489.SGD","LU1291159041.SGD","LU0511384066.AUD","LU1032955483.USD","BK4561","LU2506951958.HKD","LU2168564495.EUR","LU1043141396.HKD","LU0861579265.USD","LU2471134796.USD","BK4554","LU0302445910.USD","LU1366192091.USD","LU1261432733.SGD","QCOM","LU1670711040.USD","LU2322448957.HKD","LU2473716301.USD","LU0198837287.USD","LU0256863811.USD","BK4559","LU1935043536.SGD","LU0070302665.USD","LU2112291526.USD","IE00BMPRXR70.SGD","LU1989772840.SGD","GB00BDT5M118.USD","IE00B7SZLL34.SGD","LU0096362180.USD","MACW.SI","HK0000304805.HKD","LU1496350171.SGD","LU1868836757.USD","LU0289941410.SGD","LU1303367103.USD","LU2324357040.USD","HK0000819398.USD","LU0210536198.USD","LU2242650005.HKD","LU2430703251.USD","LU1196500208.SGD","LU2125909593.SGD","BK4548","LU0444973449.USD","LU2092627202.USD","LU0276348264.USD","LU0708994859.HKD","IE00BQXX3F31.USD","LU0211327993.USD","LU1116320901.HKD","LU0130518102.USD","IE000F7OJYX1.SGD","LU1670710588.SGD","LU0211326839.USD","BK4585","LU0882574139.USD","BK4577","LU2430703178.SGD","LU2250418816.HKD","LU1894683264.USD","LU0320765992.SGD","LU1670710661.SGD","LU0256863902.USD","BK4515","LU0689626769.HKD","LU2462591350.SGD","LU0077335932.USD","LU2462591277.SGD","LU0823421333.USD","BK4550","HK0000320223.HKD","LU2506952170.USD","LU1989773731.SGD","LU0265550359.USD","MSFX","LU0385154629.USD","LU0690374961.EUR","TSLA","BK4605","LU2125154935.USD","LU1564329032.USD","BK4538","LU0069063385.USD","LU0289739699.SGD","LU1119994496.HKD","LU0879622024.SGD","IE00BN8TJ469.HKD","LU1221951046.USD","LU2083900584.USD","GOU","IE00BWXC8680.SGD","LU0345768153.USD","APLY","LU2750360641.GBP","LU1712237335.SGD","LU0494093205.USD","LU2089984988.USD","LU2458330169.SGD","LU2458330243.SGD","LU0353189680.USD","LU0124676726.USD","LU0251131958.USD","LU1093756325.SGD","LU1674673428.USD","LU0345769128.USD","HK0000306685.HKD","LU1699723380.USD","GB00B4LPDJ14.GBP","LU1316542783.SGD","LU0210528500.USD","LU2237443895.HKD","LU0052756011.USD","LU0289739343.SGD","LU2404859741.USD","IE00B2B36J28.USD","LU0345768740.USD","LU2347655073.USD","LU2462157665.USD","LU0390134368.USD","IE00BVYPNP33.GBP","LU2271345857.HKD","LU0203347892.USD","LU1718418525.SGD","LU2168564065.EUR","LU2210149790.SGD","LU0312595415.SGD","LU0234572021.USD","GB00B4QBRK32.GBP","LU0345769631.USD","LU1430594728.SGD","LU1861558580.USD","LU2592432038.USD","BK4602","LU2896262040.SGD","LU1181866309.USD","LU0757359954.USD","LU2244417387.USD","LU1778281490.HKD","LU0310799852.SGD","LU0553294199.USD","LU2347655156.SGD","BK4599","LU1267930490.SGD","HK0000320264.USD","LU0211328371.USD","LU0006306889.USD","LU2413666426.HKD","BK4503","LU2746668974.SGD","AAPD","LU0175139822.USD","LU0072461881.USD","LU1074936037.SGD","LU2191332357.HKD","IE00BKPKM429.USD","LU0472753341.HKD","LU0994945656.USD","LU2420271590.USD","IE000MB6IJN5.SGD","LU1923622614.USD","LU0138981039.USD","BK4573","LU0347712357.USD","LU1267930813.SGD","SG9999000418.SGD","LU0158827948.USD","LU1228905540.USD","LU2168564222.USD","LU0477156953.USD","BK4576","LU0320765059.SGD","LU1280957306.USD","LU1564329628.SGD","LU1791710400.SGD","LU1046421795.USD","LU1043141123.HKD","LU0162691827.USD","LU1732799900.SGD","IE00BKVL7J92.USD","IE00B1BXHZ80.USD","LU2063271972.USD","IE00B4R5TH58.HKD","LU2552382215.SGD","BK4501","LU2168563687.JPY","LU0795875169.SGD","LU1992135472.HKD","LLII","LU0061474705.USD","LU1642822529.SGD","LU1582987597.SGD","LU1868836914.USD","LU0079474960.USD","LU0130102774.USD","LU0784385170.HKD","LU2237438978.USD","LU0154236417.USD","LU0345774391.USD","LU0444971666.USD","LU0130517989.USD","LU1366333091.USD","SG9999015986.USD","LU1400636491.USD","LU0109394709.USD","LU1201861165.SGD","LU1697837992.HKD","BK4507","LLY","LU0082616367.USD","LU0471298777.SGD","IE00BK4W5L77.USD","LU1116320737.USD","LU0784383803.USD","IE00B4JS1V06.HKD","IE00BFSS8Q28.SGD","LU2211815571.USD","LU1232071149.USD","LU2242649171.HKD","META","LU1429558221.USD","BK4528","LU0648001328.SGD","IE00BLSP4452.SGD","LU1935043023.USD","LU2247934214.USD","LU0057025933.USD","IE0034235303.USD","LU2023250504.SGD","LU2237443622.USD","IE000YTNTUN2.SGD","LU1894683348.USD","LU1059921491.USD","LU2236285917.USD","BK4512","IE00BJJMRX11.SGD","LU1633808545.USD","LU1934455194.USD","LU0820561818.USD","IE0004091025.USD","QCML","LU1804176565.USD","LU2491050154.USD","LU0496365809.HKD","GOOY","LU2750360997.AUD","IE00BYQQ9H92.USD","SG9999014898.SGD","LU0158827781.USD","LU2097829019.USD","LU0985320562.USD","LU1721428933.USD","BK4534","IE00B19Z3B42.SGD","LU2361044949.HKD","SG9999001176.USD","BK4553","IE0005OL40V9.USD","LU1235295455.SGD","LU2237443465.HKD","ELIL","LU2764263039.SGD","LU2272731865.HKD","LU0053666078.USD","LU1201861249.SGD","LU0477156797.USD","BK4567","LU0072462426.USD","LU0122379950.USD","LU0683600562.USD","LU2360108059.USD","SG9999015978.USD","LU1861127337.USD","IE00BJJMRY28.SGD","LU0109391861.USD","LU0011850046.USD","IE00B4YYXB79.USD","IE00BFMHRM44.USD","SG9999017495.SGD","LU0432979614.USD","LU1868836591.USD","GOOX","LU0738911758.USD","LU0353189763.USD","LU1880398471.USD","LU1267930730.SGD","LU0109392836.USD","LU1670711123.USD","IE00B7KXQ091.USD","LU0234570918.USD","LU0708995401.HKD","IE0034235295.USD","LU1145028129.USD","LU1236620750.USD","LU1992135399.USD","LU0061475181.USD","GGLS","IE00BMPRXN33.USD","IE0002141913.USD","SG9999014559.SGD","LU0225283273.USD","LU0266013472.USD","LU0528227936.USD","LU1989771016.USD","LU2505996509.AUD","LU2487616109.SGD","IE00BJLML261.HKD","IE00B5949003.HKD","LU0267386448.USD","IE00B775SV38.USD","LU2720916845.USD","LU0211331839.USD","LU0792757196.USD","LU1121112475.USD","LU1720051108.HKD","LU0719512351.SGD","LU1267930227.SGD","AAPB","LU0823417737.USD","LU0345770308.USD","LU0323239441.USD","LU0211326755.USD","LU1244550221.USD","LU1623119135.USD","LU2360106947.USD","IE0034235188.USD","SG9999018865.SGD","LU2381873111.SGD","GOOP","SG9999013999.USD","LU0823416689.USD","LU1057294990.SGD","LU0417517546.SGD","LU2361045086.USD","LU1582986359.USD","LU0965509010.AUD","LU1852331112.SGD","LU0640476718.USD","LU2065171402.SGD","BK4588","LU1989764664.SGD","LU1974910355.USD","LU0894485498.HKD","LU2092937148.SGD","LU2463028550.USD","LU2552382132.HKD","IE00BFSS7M15.SGD","LU0820561909.HKD","SG9999002224.SGD","LU0342679015.USD","LU0878866978.SGD","LU1334329650.SGD","LU0957808578.USD","LU0823434583.USD","IE00BQXX3D17.EUR","LU1548497426.USD","LU1988902786.USD","BK4007","LU1206713676.USD","LU0426417589.USD","SG9999001077.SGD","LU0868494708.USD","IE000ITXATA3.USD","LU1435385759.SGD","LU2471134523.USD","SG9999001424.SGD","IE0004086264.USD","MSFL","LU1035775433.USD","LU0787776722.HKD","LU1242518857.USD","LU0157215616.USD","LU0251132253.USD","LU0208291251.USD","LU2433249047.HKD","SG9999015952.SGD","LU0476273544.USD","SGXZ99366536.SGD","BK4604","LU0979878070.USD","LU2413666699.HKD","LU1323610961.USD","LU0433182093.SGD","LU1951198990.SGD","LU0133085943.USD","LU0466842654.USD","BK4566","IE00BJTD4V19.USD","LU0127658192.USD","IE0000B7K699.USD","LU1935042215.USD","BK4504","BK4077","LU0081259029.USD","LU0265550946.USD","LU0048584097.USD","LU0724617625.USD","LU1037948897.HKD","LU1585245621.USD","LU1691799644.USD","IE00B775H168.HKD","LU2065171311.SGD","LU2999663052.SGD","LU2756315664.SGD","LU1400636657.SGD","LU1153585028.USD","IE00BK4W5M84.HKD","LU2087625088.SGD","LU2041044095.USD","LU2237443382.USD","LU1506573853.SGD","LU1489326972.SGD","LU1066051225.USD","OWL","IE00BMPRXQ63.HKD","LU2023251221.USD","LU2326559502.SGD","IE0001KFT4U8.USD","LU1934455863.HKD","LU1674673691.USD","LU2491050071.SGD","LU2461242641.AUD","LU2089283258.USD","IE0009G5SDU7.USD","IE00BGHQDM52.EUR","LU0889565916.HKD","AAPW","LU0672654240.SGD","IE00B19Z9505.USD","LU0912757837.SGD","LU0965509283.SGD","MSFU","LU1564329115.USD","LU1551013342.USD","LU2023250330.USD","MSFO","LU1935042488.USD","IE00B19Z8X17.USD","LU2746668461.USD","LU1989763005.USD","SG9999018857.SGD","LU1571399168.USD","AMZN","LU0068578508.USD","LU1084165304.USD","LU1839511570.USD","SGXZ81514606.USD","BK4533","LU0238689110.USD","LU0323240290.USD","SG9999014914.USD","BK4170","LU2279689827.SGD","IE0009356076.USD","LU1496350502.SGD","LU1823568750.SGD","SG9999014906.USD","IE0009355771.USD","LU0871640123.AUD","QCMD","IE0003U64NQ7.SGD","LU0642271901.SGD","IE000BZT7R73.USD","SG9999014880.SGD","LU0215105999.USD","LU0056508442.USD","BK4581","LU2272731782.SGD","LU1069347547.HKD","LU0949170426.SGD","MSFD","LU0965508806.USD","LU1670627923.USD","LU0471298694.HKD","LU1093756168.USD","LU1983260115.SGD","LU0820562030.AUD","BK4587","IE000W1ABFV2.USD","LU1861559042.SGD","LU2430703095.HKD","BK4524","LU1983299246.USD","LU2213496289.HKD","LU1670628061.USD","LU2491049909.HKD","LU1803068623.USD","LU0061474960.USD","LU1340139317.AUD","LU1914381329.SGD","LU1023059063.AUD","LU1127390331.HKD","LU0203201768.USD","IE00BVYPNQ40.USD","IE00BLSP4239.USD","LU2404859667.USD","LU0310800379.SGD","SGXZ57979304.SGD","LU1267930573.SGD","SG9999015945.SGD","LU2322448791.USD","IE00BYXW3230.USD","LU0097036916.USD","LU1035773651.USD","IE00BHPRN162.USD","LU2362541513.USD","IE00BFXG0V08.USD","LU0114720955.EUR","LU1868837300.USD","LU2065169927.USD","LU1814569148.SGD","LU0980610538.SGD","HK0000304797.USD","LU0130103400.USD","IE00BJTD4N35.SGD","GGLL","QCMU","BK4525","LU0742534661.SGD","LU2237957811.SGD","LU2065170008.USD","LU2077746001.SGD","LU1629891620.HKD","LU0976567544.SGD","IE00BN29S564.USD","LU2764262908.HKD","BK4579","LU1242518931.SGD","LU0426412945.USD","LU1645745479.HKD","IE00BDCRKT87.USD","LU2362541273.HKD","LU2237443549.SGD","LU0094547139.USD","LU0823417653.USD","LU1400636574.HKD","LU0048573561.USD","AAPX","SG9999001176.SGD","LU2108987350.USD","LU0070217475.USD","LU2317271919.USD","LU2125154778.USD","LU2764263203.CNY","BK4505","HK0000532082.HKD","LU0323591593.USD","LU2506952097.USD","LU0943347566.SGD","LU2133065610.SGD","LU1564329461.SGD","LU2168564149.EUR","LU2111349929.HKD","BK4571","AAPL","LU1228905037.USD","IE00BSNM7G36.USD","LU1989772923.USD","BK4598","IE0004445239.USD","MSFT","LU2471134952.CNY","LU0957791311.USD","BK4516","LU2298321311.HKD","LU0757359368.USD","LU0786609619.USD","LU1935042991.SGD","LU0868494617.USD","HK0000914686.HKD","IE00BZ1G4Q59.USD","LU0314104364.USD","LU2098885051.SGD","LU0726765562.USD","LU0823434740.USD","LU1934455277.USD","LU1803068979.SGD","LU2505996681.GBP","LU2264538146.SGD","SG9999004303.SGD","LU2097344431.USD","LU2095319765.USD","IE00B19Z8W00.USD","LU1868837136.USD","LU2637965513.SGD","BK4575","LU1732800096.USD","LU2471134879.HKD","LU1923623000.USD","LU2275660780.HKD","MSFW","IE00B5TLWC47.USD","LU2054465674.USD","IE00BDRTCR15.USD","LU2089284900.SGD","GOOGL","LU0345770993.USD","LU2456880835.USD","LU0823421416.USD","LU3102509885.SGD","LU1061106388.HKD","IE0004445015.USD","GOOW","LU0965509101.SGD","LU0552385451.USD","LU2148611432.USD","LU2357305700.SGD","SG9999014575.USD","SG9999014567.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1114128860","title":"Phibro Animal Health Corporation将循环信贷额度提升1.25亿美元至4.35亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114128860","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114128860?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:42","pubTimestamp":1777581731,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会(SEC)的文件显示，Phibro Animal Health Corporation已将其循环信贷承诺额度增加了1.25亿美元。\n此次增资使该公司的总循环信贷额度从原先的水平提升至4.35亿美元。这一举措显著增强了Phibro Animal Health的财务灵活性和运营资金储备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAHC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101358695","title":"强生承诺继续为已终止的CD20单靶点及CD19-CD20双靶点CAR-T研究项目患者提供支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1101358695","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101358695?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:33","pubTimestamp":1777581199,"startTime":"0","endTime":"0","summary":"强生公司宣布，尽管已决定终止其研究性CD20单靶点CAR-T细胞疗法及CD19-CD20双靶点CAR-T项目的开发，公司仍将恪守承诺，继续为参与这些临床试验的患者提供支持。\n这一决定体现了强生对患者安全与福祉的一贯重视。在药物研发过程中，即使项目终止，确保已入组患者能够获得必要的医疗关怀与后续支持至关重要。\nCD20单靶点与CD19-CD20双靶点CAR-T疗法均属于前沿的细胞免疫治疗领域，旨在通过改造患者自身的T细胞来靶向攻击癌细胞。虽然这些特定项目不再推进，强生仍在肿瘤学领域拥有广泛的研发管线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","IE00BJT1NW94.SGD","LU0820561818.USD","BK4581","LU0124676726.USD","LU2750360641.GBP","LU1935042991.SGD","IE00BKVL7J92.USD","IE000MB6IJN5.SGD","LU1551013425.SGD","LU2471134523.USD","LU1496350502.SGD","IE000WAW04H5.SGD","LU0683600562.USD","LU1674673691.USD","IE000SO60NU8.SGD","LU1221951046.USD","LU2750360997.AUD","LU1032955483.USD","IE00BBT3K403.USD","LU1629891620.HKD","LU2505996509.AUD","BK4532","LU0792757196.USD","LU0889566641.SGD","LU1244550577.SGD","LU0964807845.USD","LU1585245621.USD","LU2896262040.SGD","IE00BJJMRZ35.SGD","LU0320765646.SGD","LU1023059063.AUD","LU1506573853.SGD","LU0345770993.USD","LU1221951129.SGD","BK4592","BK4534","LU2347655156.SGD","LU0203345920.USD","LU0689626769.HKD","LU1894683348.USD","LU2602419157.SGD","LU2112291526.USD","IE00BFXG1179.USD","LU2468319806.SGD","BK4550","IE0000B7K699.USD","LU1066051225.USD","LU2592432038.USD","SG9999001176.SGD","LU0820561909.HKD","LU1196500208.SGD","LU2487616109.SGD","LU0234572021.USD","LU2430703251.USD","LU0098860793.USD","LU0058720904.USD","LU1280957306.USD","LU1894683264.USD","LU0994945656.USD","LU1983299246.USD","SGXZ57979304.SGD","LU2430703095.HKD","BK4568","IE00BLSP4452.SGD","LU2213496289.HKD","BK4504","IE00B1BXHZ80.USD","LU0640476718.USD","LU1059921491.USD","SG9999001176.USD","LU0203347892.USD","IE00BSNM7G36.USD","LU2133065610.SGD","IE0001KFT4U8.USD","SG9999002232.USD","IE00BZ1G4Q59.USD","LU0053666078.USD","LU1066053197.SGD","LU1121112475.USD","IE0034235303.USD","IE00BVYPNV92.GBP","LU0795875169.SGD","LU1032466523.USD","LU0426417589.USD","IE000M9KFDE8.USD","LU2756315318.SGD","IE00B19Z3B42.SGD","LU2471134952.CNY","LU0114720955.EUR","LU2129689431.USD","LU0820562030.AUD","LU2756315664.SGD","LU1778281490.HKD","JNJ","IE00BLSP4239.USD","LU0210536198.USD","SG9999002224.SGD","IE000BZT7R73.USD","IE00BFTCPJ56.SGD","LU1914381329.SGD","IE00B3PB1722.GBP","LU1261432733.SGD","LU1718418525.SGD","LU0912757837.SGD","LU1061106388.HKD","LU2023250330.USD","IE00B19Z3581.USD","LU0345770308.USD","LU1043141396.HKD","LU2505996681.GBP","LU0210528500.USD","LU2471134796.USD","LU1551013342.USD","SG9999001440.SGD","LU0070217475.USD","LU0882574055.USD","LU2471134879.HKD","LU1162221912.USD","SG9999013999.USD","IE00BVYPNW00.USD","LU1244550494.USD","LU1929549753.HKD","LU0795875086.SGD","LU2430703178.SGD","LU1066051811.HKD","BK4588","LU0787776722.HKD","LU1066051498.USD","LU0466842654.USD","IE00BN8TJ469.HKD","BK4559","LU0985320562.USD","LU1267930813.SGD","LU1043141123.HKD","BK4007","LU2129689514.USD","IE00BGHQF631.EUR","LU1430594728.SGD","IE0002141913.USD","BK4585","LU1057294990.SGD","LU1732800096.USD","LU0943347566.SGD","LU2089984988.USD","LU2129689605.HKD","LU0689472784.USD","LU0289739699.SGD","LU0122379950.USD","IE0002270589.USD","IE00B42XCP33.USD","LU1244550221.USD","BK4533","IE00B3T34201.USD","IE0009355771.USD","LU0234570918.USD","LU0345769128.USD","LU1674673428.USD","IE00B4R5TH58.HKD","IE000F7OJYX1.SGD","LU0426412945.USD","LU1732799900.SGD","LU1145028129.USD","IE00BDGV0183.EUR","LU1074936037.SGD","IE00B2B36J28.USD","LU0345769631.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104567260","title":"Contineum Therapeutics公司Pipe-791药物1B期临床试验达到安全性与耐受性主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1104567260","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104567260?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:07","pubTimestamp":1777579626,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics公司宣布，其研发的Pipe-791在1B期临床试验中成功达到安全性及耐受性的主要研究终点。这一重要进展为后续临床开发奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166283059","title":"Trevi Therapeutics宣布在美国胸科学会2026年国际会议上进行口头报告及多篇海报展示","url":"https://stock-news.laohu8.com/highlight/detail?id=1166283059","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166283059?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:06","pubTimestamp":1777579591,"startTime":"0","endTime":"0","summary":"Trevi Therapeutics公司近日宣布，其研究成果已获选在美国胸科学会（ATS）2026年国际会议上进行展示。此次入选包括一场重磅的口头学术报告以及多篇壁报展示，彰显了该公司在呼吸疾病治疗领域的科研实力。\n该会议是全球呼吸病学领域的权威学术盛会，汇集了来自世界各地的顶尖专家学者。Trevi Therapeutics此次多项研究成果同时获得展示机会，反映了行业对其创新疗法的高度关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRVI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146134593","title":"Contineum Therapeutics公布慢性疼痛探索性Pipe-791 1B期试验积极顶线数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1146134593","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146134593?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:06","pubTimestamp":1777579590,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics宣布其针对慢性疼痛的探索性Pipe-791 1B期临床试验获得积极顶线结果。这项关键研究标志着该公司在疼痛管理领域的重要进展。试验数据为后续临床开发提供了有力支持，展现出该疗法在慢性疼痛治疗中的潜在价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194346361","title":"Axsome Therapeutics宣布FDA批准Auvelity®用于治疗阿尔茨海默病相关痴呆激越症状","url":"https://stock-news.laohu8.com/highlight/detail?id=1194346361","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194346361?lang=zh_cn&edition=full","pubTime":"2026-05-01 02:08","pubTimestamp":1777572495,"startTime":"0","endTime":"0","summary":"生物制药公司Axsome Therapeutics宣布，其创新药物Auvelity®（右美沙芬氢溴酸盐与安非他酮盐酸盐复方制剂）已获得美国食品药品监督管理局（FDA）批准，用于治疗由阿尔茨海默病引起的痴呆相关的激越症状。\n此次获批标志着Auvelity®在现有适应症基础上的重要拓展，为阿尔茨海默病相关激越症状的治疗提供了新的药物选择。激越症状是痴呆患者常见的神经精神症状，对患者及其照护者的生活质量构成显著挑战。\nAuvelity®作为一种新型口服疗法，其独特的双重作用机制旨在调节与情绪和行为相关的神经递质系统。该药物的批准基于其临床试验中展现出的有效性和安全性数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM","BK4585","BK4007","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631651431","title":"美国FDA提议将诺和诺德、礼来减肥药移出批量配药清单，两家药企迎来利好","url":"https://stock-news.laohu8.com/highlight/detail?id=2631651431","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631651431?lang=zh_cn&edition=full","pubTime":"2026-04-30 23:36","pubTimestamp":1777563360,"startTime":"0","endTime":"0","summary":" 美国食品药品监督管理局提议，将诺和诺德与礼来旗下爆款肥胖及糖尿病药物的活性成分，从外包机构可用于批量配药的药品目录中剔除。 若该提案最终落地，此举将限制这类药物的大规模仿制调配生产；除非相关药品被列入 FDA药品短缺清单，否则不得批量配药。 FDA 在公告中称，目前不存在临床必要性，需要外包机构使用原料药批量调配上述药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-30/doc-inhwhzrz7241664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2168564495.EUR","LU2361045086.USD","SGXZ99366536.SGD","LU2264538146.SGD","LU0266013472.USD","IE00B775H168.HKD","LU0353189680.USD","LU2237443895.HKD","LU2360106947.USD","LU1551013425.SGD","SGXZ81514606.USD","LU2552382058.USD","SG9999001176.SGD","LU1064131342.USD","LU2108987350.USD","LU0823434583.USD","LU0225283273.USD","LU0114720955.EUR","LU0289739699.SGD","LU1988902786.USD","LU1989771016.USD","IE0004445015.USD","LU0323591593.USD","LU2746668461.USD","LU2896262040.SGD","LU2750360641.GBP","LU2237438978.USD","IE00BWXC8680.SGD","LU2236285917.USD","LU2361044949.HKD","LU0158827781.USD","LU2491050071.SGD","LU1814569148.SGD","LU0471298777.SGD","LU1917777945.USD","IE0002141913.USD","LU2461242641.AUD","SG9999017495.SGD","SG9999015986.USD","LU0385154629.USD","LU0320765059.SGD","LU0640476718.USD","LU0079474960.USD","SG9999014906.USD","IE00BZ1G4Q59.USD","LU2089284900.SGD","BK4599","BK4534","LU0158827948.USD","LU1629891620.HKD","LU2111349929.HKD","LU0456855351.SGD","LU1868836757.USD","LU2089984988.USD","LLYZ","GB00BDT5M118.USD","LU0466842654.USD","SG9999015978.USD","BK4581","LU2089283258.USD","LLY","BK4588","ELIS","IE00BJT1NW94.SGD","LU0006306889.USD","LU2552382215.SGD","LU0210536198.USD","LU2750360997.AUD","LU1093756325.SGD","LU0154236417.USD","IE0005OL40V9.USD","LU0471298694.HKD","SG9999014914.USD","LU0256863902.USD","LU1623119135.USD","LU1551013342.USD","ELIL","LU2756315664.SGD","IE00BFTCPJ56.SGD","LU0234572021.USD","IE00BKVL7J92.USD","LU0823416689.USD","LU1868836591.USD","LU1145028129.USD","LU1868837136.USD","IE00B1XK9C88.USD","IE00BFSS8Q28.SGD","LU2471134523.USD","LU0820561818.USD","LU2361044865.SGD","LU2023251221.USD","SG9999014880.SGD","IE00B4JS1V06.HKD","LU1323610961.USD","LU2324357040.USD","NVO","BK4585","LU0109391861.USD","LU0672654240.SGD","LU2746668974.SGD","LU0203201768.USD","LU0198837287.USD","LU0964807845.USD","LU2168564149.EUR","SG9999015945.SGD","LU0820562030.AUD","LU2063271972.USD","LU2168564065.EUR","IE00B2B36J28.USD","LU2237443549.SGD","LU1232071149.USD","IE00B7KXQ091.USD","SG9999013999.USD","LU0203202063.USD","LU0256863811.USD","LU1035775433.USD","IE00BK4W5L77.USD","LU1720051108.HKD","LU0354030438.USD","LU0943347566.SGD","LU1720051017.SGD","SG9999015952.SGD","SGXZ57979304.SGD","IE0009355771.USD","LU0106261372.USD","LU2456880835.USD","SGXZ31699556.SGD","LU1280957306.USD","IE00BKPKM429.USD","LU2028103732.USD","LU0823434740.USD","IE00B1BXHZ80.USD","LU0882574055.USD","LU2237443465.HKD","LU0708995401.HKD","LU0109394709.USD","LU0786609619.USD","LU1366192091.USD","LU1291159041.SGD","SG9999001176.USD","LU0133085943.USD","IE0004445239.USD","LU2112291526.USD","LU0094547139.USD","IE00BN29S564.USD","LU2237443622.USD","LU1868836914.USD","LU2213496289.HKD","IE00BJLML261.HKD","LU0683600562.USD","LU0889565916.HKD","SG9999018857.SGD","LU0122379950.USD","LU2471134879.HKD","LU0882574139.USD","LU2087625088.SGD","LU0417517546.SGD","LU0316494557.USD","LU2552382132.HKD","LU0353189763.USD","LU2023250330.USD","IE00BJJMRX11.SGD","LU1868837300.USD","LU1023059063.AUD","IE0001KFT4U8.USD","LU0238689110.USD","LU1983299246.USD","NVOX","LLII","LLYX","LU1548497426.USD","LU2491050154.USD","LU1093756168.USD","LU2211815571.USD","LU0432979614.USD","LU2491049909.HKD","LU0061475181.USD","LU2756315318.SGD","LU0820561909.HKD","LU2468319806.SGD","LU1712237335.SGD","LU2168563687.JPY","IE00BJJMRY28.SGD","BK4532","LU2237443978.SGD","IE00BKDWB100.SGD","LU0320765992.SGD","LU1974910355.USD","LU2168564222.USD","LU2265009873.SGD","BK4533","LU0354030511.USD","LU1267930730.SGD","LU0058720904.USD","LU0097036916.USD","LU2417539215.USD","SG9999014898.SGD","LU2471134796.USD","LU0689472784.USD","LU1127390331.HKD","LU1069344957.HKD","IE00BFSS7M15.SGD","LU1057294990.SGD","LU2602419157.SGD","IE00B4R5TH58.HKD","LU2271345857.HKD","LU2462157665.USD","SGXZ51526630.SGD","LU2471134952.CNY","IE00BJJMRZ35.SGD","IE00BK4W5M84.HKD","LU1061106388.HKD","LU2237443382.USD","LU2023250504.SGD","NVOH","LU2357305700.SGD","BK4007","LU1804176565.USD","LU2106854487.HKD","SG9999018865.SGD","BK4516","LU0096364046.USD","LU0787776722.HKD"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.0998},{"period":"3month","weight":0.0414},{"period":"6month","weight":0.0566},{"period":"1year","weight":0.2904},{"period":"ytd","weight":0.0568}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"name":"制药","nameEN":"BK4007"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"制药(BK4007)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供制药(BK4007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"制药,BK4007,制药股票,制药股票老虎,制药股票老虎国际,制药行情,制药股票行情,制药股价,制药股市,制药股票价格,制药股票交易,制药股票购买,制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"制药(BK4007)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供制药(BK4007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}